Silicosis Treatment

Treatment options for silicosis can significantly improve patients’ quality of life by addressing disease symptoms. In very rare cases, a lung transplant can extend survival and improve quality of life.

Silicosis is a permanent, irreversible lung disease caused by long-term exposure to silica dust. Removing the source of silica exposure can help prevent further damage and avoid symptom exacerbation.

Supportive or palliative treatments for silicosis manage specific symptoms. Relieving symptoms such as coughing or shortness of breath can improve comfort.

Bronchodilators, for example, can make breathing easier. There are three main types of bronchodilators: Beta-2 agonists and anticholinergics that are typically administered with an inhaler and Theophylline, which is a tablet.

Individual patients may benefit from a combination of treatments depending on displayed symptoms and their severity. Care also includes fighting secondary infections and reducing risks of complications. Avoiding respiratory illnesses is particularly critical in silicosis patients whose lung function is already compromised.

Eliminating exposure to silica dust can help prevent further damage and lessen the disease’s progression. Workplace protections such as wearing respirators and avoiding bringing home dust-covered clothing and gear can help limit silica dust exposure for workers and their families.

Whole Lung Lavage

Whole lung lavage (WWL) is a procedure that uses a saline solution to flush out the lungs. Sometimes called lung washing, it removes debris and damaged cells from within the lungs.

Patients receive general anesthesia during the procedure. A pulmonary specialist then inserts a thin tube into one lung. Using a bronchoscope to view the lung’s interior, saline solution is added to bathe the lung. The fluid is collected as it drains to ensure its complete removal.

Because general anesthesia is used, it’s typically preferred to perform whole lung lavage on both lungs at once. Patients may experience coughing as the lungs finish clearing and need supplemental oxygen for a few days after the procedure.

Researchers have examined the use of whole-lung lavage (WLL) earlier in silicosis, before severe scarring appears. This medical procedure washes a patient’s lungs with saline by repeatedly filling and draining them.

A 2024 study in Australia, published in the Journal of Thoracic Disease, found that WLL is a safe treatment for people with artificial stone silicosis when performed at specialized hospitals with extensive experience. It may help some patients, but not everyone. The researchers wrote that more studies are needed to find out who can benefit most.

Medications

Physicians use several medications to address silicosis. Many of these were originally developed to treat other types of lung disease or fibrosis. Because they continue to demonstrate effectiveness in treating silicosis, they’re widely used.

Silicosis medications can disrupt the scarring process from silica dust in the lungs. Doctors weigh each patient’s medical history and overall health before choosing an appropriate treatment.

Recent clinical studies have examined drugs such as pirfenidone (Esbriet, Pirespa) and nintedanib (Ofev) in people with silicosis and other types of lung fibrosis. 

The studies are still small and not yet large placebo-controlled trials, but they are looking into whether these drugs might slow lung scarring and improve breathing for some patients.

Patients may be treated with one or more of these medications. These treatments have demonstrated effectiveness in helping to improve lung function and slow disease progression.

Lung Transplant Surgery

Lung transplant surgery is a well-established treatment option for several late-stage lung diseases. It can be an effective treatment for some eligible patients with end-stage silicosis.

During the procedure, a surgeon removes a patient’s lungs and replaces them with healthy donor lungs. While avoiding silica dust exposure will protect the new lungs from developing silicosis, conditions specific to the disease, such as excess bleeding and unstable blood flow, may complicate the procedure and recovery process.

Lung transplantation is a complex procedure that comes with many risks and a complex set of requirements that recipients must adhere to for the rest of their lives. Patients must be fully aware of the risks and requirements before committing to the procedure.

Lung transplants are sometimes optional treatment for advanced silicosis. Long-term survival is “not significantly different” to the general population of lung transplant patients, according to a study in the journal Lung. 

Since treatment and lost wages can be costly, many workers with silicosis have taken legal action against employers or product manufacturers, saying that better dust controls and training could have prevented their illness. These silicosis lawsuits are helping some families pay for medical care and long-term support.

Lifestyle changes can be an effective natural silicosis treatment. Quitting smoking can greatly improve lung function, and a nutritious diet can benefit overall health. Because silicosis limits lung function, patients should always discuss any new exercise program with their doctor before starting.

Limited animal studies show some natural compounds might slow fibrosis, for example, orchid extract (bletilla striata polysaccharide), amino acids, flavonoids and oleanolic acid (in olive and grapeseed oils). However, the FDA doesn’t regulate supplements as medications and cautions: “Vitamins, minerals, herbs, and other dietary supplements are not FDA-approved to treat or prevent disease.”

Patients may explore natural remedies for a number of reasons, including the high cost of medical treatment. The economic impact of treatment and lost wages is leading a growing number of workers diagnosed with silicosis to file silicosis lawsuits seeking financial compensation for silica exposure.

People diagnosed with silicosis are at increased risk of developing tuberculosis compared to the general public. Receiving a TB vaccine may reduce this risk.

Silica particles increase the replication of a bacterium (Mycobacterium tuberculosis) that likely contributes to increased susceptibility to TB. Additionally, studies of rats with silicosis suggest that silicosis severity negatively affects the ability to fight off TB infection.

Additional health risks associated with a silicosis diagnosis include chronic obstructive pulmonary disease, kidney disease and pulmonary hypertension. Patients should discuss concerns about these conditions with their healthcare provider to develop an appropriate preventative plan.